composto heterocíclico e composição farmacêutica do mesmo
The present invention provides a heterocyclic compound represented by General Formula (1): wherein R1 is a group R5-Z1-, etc., Z1 is a lower alkylene group, etc., and R5 is a group represented by General Formula; wherein R13 is a hydrogen atom, etc., m is an integer from 1 to 5; R2 is a hydrogen ato...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | por |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | NORIKAZU HASHIMOTO TAKUMI SUMIDA NAOTO OHI YASHUO HARADA SHIGEKAZU FUJITA KEIZO KAN HIDEKI TAKASU KENJI YOSHIDA HIRONORI MATSUYAMA MASATOSHI IIDA TAE FUKUSHIMA KEISUKE MIYAJIMA TAKASHI NAKAGAWA MAKOTO SAKAMOTO |
| description | The present invention provides a heterocyclic compound represented by General Formula (1): wherein R1 is a group R5-Z1-, etc., Z1 is a lower alkylene group, etc., and R5 is a group represented by General Formula; wherein R13 is a hydrogen atom, etc., m is an integer from 1 to 5; R2 is a hydrogen atom: Y is CH or N: A1 is a heterocyclic ring selected from the group consisting of indolediyl groups, wherein the heterocyclic ring may have at least one substituent: T is a group -CO-, etc.: R3 is a hydrogen atom, etc.: R4 is a lower alkyl group optionally substituted by one or more hydroxy groups, etc.: R3 and R4, together with the nitrogen atom to which they bind, may bind to each other and form a 5- to 10-membered saturated heterocyclic ring, wherein the heterocyclic ring may have at least one substituent. The heterocyclic compound of the present invention has excellent effects of suppressing the production of collagen and/or treating tumors. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BRPI0819232A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BRPI0819232A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BRPI0819232A23</originalsourceid><addsrcrecordid>eNrjZLBNzs8tyC8uyVfISC1JLcpPPrw2OSczOV8hVQEik3l4-eHF-QppiUW5icmHV5WWZCYnKqTkK-SmFufm8zCwpiXmFKfyQmluBiU31xBnD93Ugvz41OKCxOTUvNSSeKegAE8DC0NLI2MjRyNjohQBAAFMNAs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>composto heterocíclico e composição farmacêutica do mesmo</title><source>esp@cenet</source><creator>NORIKAZU HASHIMOTO ; TAKUMI SUMIDA ; NAOTO OHI ; YASHUO HARADA ; SHIGEKAZU FUJITA ; KEIZO KAN ; HIDEKI TAKASU ; KENJI YOSHIDA ; HIRONORI MATSUYAMA ; MASATOSHI IIDA ; TAE FUKUSHIMA ; KEISUKE MIYAJIMA ; TAKASHI NAKAGAWA ; MAKOTO SAKAMOTO</creator><creatorcontrib>NORIKAZU HASHIMOTO ; TAKUMI SUMIDA ; NAOTO OHI ; YASHUO HARADA ; SHIGEKAZU FUJITA ; KEIZO KAN ; HIDEKI TAKASU ; KENJI YOSHIDA ; HIRONORI MATSUYAMA ; MASATOSHI IIDA ; TAE FUKUSHIMA ; KEISUKE MIYAJIMA ; TAKASHI NAKAGAWA ; MAKOTO SAKAMOTO</creatorcontrib><description>The present invention provides a heterocyclic compound represented by General Formula (1): wherein R1 is a group R5-Z1-, etc., Z1 is a lower alkylene group, etc., and R5 is a group represented by General Formula; wherein R13 is a hydrogen atom, etc., m is an integer from 1 to 5; R2 is a hydrogen atom: Y is CH or N: A1 is a heterocyclic ring selected from the group consisting of indolediyl groups, wherein the heterocyclic ring may have at least one substituent: T is a group -CO-, etc.: R3 is a hydrogen atom, etc.: R4 is a lower alkyl group optionally substituted by one or more hydroxy groups, etc.: R3 and R4, together with the nitrogen atom to which they bind, may bind to each other and form a 5- to 10-membered saturated heterocyclic ring, wherein the heterocyclic ring may have at least one substituent. The heterocyclic compound of the present invention has excellent effects of suppressing the production of collagen and/or treating tumors.</description><language>por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161101&DB=EPODOC&CC=BR&NR=PI0819232A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161101&DB=EPODOC&CC=BR&NR=PI0819232A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NORIKAZU HASHIMOTO</creatorcontrib><creatorcontrib>TAKUMI SUMIDA</creatorcontrib><creatorcontrib>NAOTO OHI</creatorcontrib><creatorcontrib>YASHUO HARADA</creatorcontrib><creatorcontrib>SHIGEKAZU FUJITA</creatorcontrib><creatorcontrib>KEIZO KAN</creatorcontrib><creatorcontrib>HIDEKI TAKASU</creatorcontrib><creatorcontrib>KENJI YOSHIDA</creatorcontrib><creatorcontrib>HIRONORI MATSUYAMA</creatorcontrib><creatorcontrib>MASATOSHI IIDA</creatorcontrib><creatorcontrib>TAE FUKUSHIMA</creatorcontrib><creatorcontrib>KEISUKE MIYAJIMA</creatorcontrib><creatorcontrib>TAKASHI NAKAGAWA</creatorcontrib><creatorcontrib>MAKOTO SAKAMOTO</creatorcontrib><title>composto heterocíclico e composição farmacêutica do mesmo</title><description>The present invention provides a heterocyclic compound represented by General Formula (1): wherein R1 is a group R5-Z1-, etc., Z1 is a lower alkylene group, etc., and R5 is a group represented by General Formula; wherein R13 is a hydrogen atom, etc., m is an integer from 1 to 5; R2 is a hydrogen atom: Y is CH or N: A1 is a heterocyclic ring selected from the group consisting of indolediyl groups, wherein the heterocyclic ring may have at least one substituent: T is a group -CO-, etc.: R3 is a hydrogen atom, etc.: R4 is a lower alkyl group optionally substituted by one or more hydroxy groups, etc.: R3 and R4, together with the nitrogen atom to which they bind, may bind to each other and form a 5- to 10-membered saturated heterocyclic ring, wherein the heterocyclic ring may have at least one substituent. The heterocyclic compound of the present invention has excellent effects of suppressing the production of collagen and/or treating tumors.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBNzs8tyC8uyVfISC1JLcpPPrw2OSczOV8hVQEik3l4-eHF-QppiUW5icmHV5WWZCYnKqTkK-SmFufm8zCwpiXmFKfyQmluBiU31xBnD93Ugvz41OKCxOTUvNSSeKegAE8DC0NLI2MjRyNjohQBAAFMNAs</recordid><startdate>20161101</startdate><enddate>20161101</enddate><creator>NORIKAZU HASHIMOTO</creator><creator>TAKUMI SUMIDA</creator><creator>NAOTO OHI</creator><creator>YASHUO HARADA</creator><creator>SHIGEKAZU FUJITA</creator><creator>KEIZO KAN</creator><creator>HIDEKI TAKASU</creator><creator>KENJI YOSHIDA</creator><creator>HIRONORI MATSUYAMA</creator><creator>MASATOSHI IIDA</creator><creator>TAE FUKUSHIMA</creator><creator>KEISUKE MIYAJIMA</creator><creator>TAKASHI NAKAGAWA</creator><creator>MAKOTO SAKAMOTO</creator><scope>EVB</scope></search><sort><creationdate>20161101</creationdate><title>composto heterocíclico e composição farmacêutica do mesmo</title><author>NORIKAZU HASHIMOTO ; TAKUMI SUMIDA ; NAOTO OHI ; YASHUO HARADA ; SHIGEKAZU FUJITA ; KEIZO KAN ; HIDEKI TAKASU ; KENJI YOSHIDA ; HIRONORI MATSUYAMA ; MASATOSHI IIDA ; TAE FUKUSHIMA ; KEISUKE MIYAJIMA ; TAKASHI NAKAGAWA ; MAKOTO SAKAMOTO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BRPI0819232A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>NORIKAZU HASHIMOTO</creatorcontrib><creatorcontrib>TAKUMI SUMIDA</creatorcontrib><creatorcontrib>NAOTO OHI</creatorcontrib><creatorcontrib>YASHUO HARADA</creatorcontrib><creatorcontrib>SHIGEKAZU FUJITA</creatorcontrib><creatorcontrib>KEIZO KAN</creatorcontrib><creatorcontrib>HIDEKI TAKASU</creatorcontrib><creatorcontrib>KENJI YOSHIDA</creatorcontrib><creatorcontrib>HIRONORI MATSUYAMA</creatorcontrib><creatorcontrib>MASATOSHI IIDA</creatorcontrib><creatorcontrib>TAE FUKUSHIMA</creatorcontrib><creatorcontrib>KEISUKE MIYAJIMA</creatorcontrib><creatorcontrib>TAKASHI NAKAGAWA</creatorcontrib><creatorcontrib>MAKOTO SAKAMOTO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NORIKAZU HASHIMOTO</au><au>TAKUMI SUMIDA</au><au>NAOTO OHI</au><au>YASHUO HARADA</au><au>SHIGEKAZU FUJITA</au><au>KEIZO KAN</au><au>HIDEKI TAKASU</au><au>KENJI YOSHIDA</au><au>HIRONORI MATSUYAMA</au><au>MASATOSHI IIDA</au><au>TAE FUKUSHIMA</au><au>KEISUKE MIYAJIMA</au><au>TAKASHI NAKAGAWA</au><au>MAKOTO SAKAMOTO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>composto heterocíclico e composição farmacêutica do mesmo</title><date>2016-11-01</date><risdate>2016</risdate><abstract>The present invention provides a heterocyclic compound represented by General Formula (1): wherein R1 is a group R5-Z1-, etc., Z1 is a lower alkylene group, etc., and R5 is a group represented by General Formula; wherein R13 is a hydrogen atom, etc., m is an integer from 1 to 5; R2 is a hydrogen atom: Y is CH or N: A1 is a heterocyclic ring selected from the group consisting of indolediyl groups, wherein the heterocyclic ring may have at least one substituent: T is a group -CO-, etc.: R3 is a hydrogen atom, etc.: R4 is a lower alkyl group optionally substituted by one or more hydroxy groups, etc.: R3 and R4, together with the nitrogen atom to which they bind, may bind to each other and form a 5- to 10-membered saturated heterocyclic ring, wherein the heterocyclic ring may have at least one substituent. The heterocyclic compound of the present invention has excellent effects of suppressing the production of collagen and/or treating tumors.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | por |
| recordid | cdi_epo_espacenet_BRPI0819232A2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | composto heterocíclico e composição farmacêutica do mesmo |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T19%3A03%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NORIKAZU%20HASHIMOTO&rft.date=2016-11-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBRPI0819232A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |